Literature DB >> 6834965

Autoimmune reactivity in Ménière's disease: a preliminary report.

G B Hughes, S E Kinney, B P Barna, L H Calabrese.   

Abstract

Autoimmune inner ear disease was first described by McCabe in 1979. The diagnosis is supported by cell mediated immune responses to inner ear membrane antigen stimulation. Meniere's disease consists of episodic vertigo, fluctuating sensorineural hearing loss, tinnitus and often aural pressure. Although most clinicians feel that Meniere's disease has no known cause, recently several researchers have suggested that some cases of Meniere's disease may be autoimmune in origin. In the present study, 10 patients with bilateral Meniere's disease were studied prospectively for autoimmune inner ear disease using both cellular and humoral immune tests. Results were compared with normal control subjects. One additional patient with Meniere's disease was identified retrospectively to have positive autoimmune test results. Preliminary conclusions suggest that at least some cases of presumed idiopathic Meniere's disease are autoimmune in origin. Therapeutic implications are significant: the addition of steroids, cytotoxic drugs and/or apheresis to conventional treatment may help prevent total deafness which otherwise might be inevitable.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6834965     DOI: 10.1002/lary.1983.93.4.410

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  24 in total

1.  Antibodies to inner ear antigens in Meniere's disease.

Authors:  L Riente; F Bongiorni; A Nacci; P Migliorini; G Segnini; A Delle Sedie; F Ursino; S Tommasi; B Fattori
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

2.  Incidence of Hypothyroidism in Meniere's Disease.

Authors:  U P Santosh; M S Sudhakar Rao
Journal:  J Clin Diagn Res       Date:  2016-05-01

3.  Non-specific immunological determinations in Meniere's disease: any role in clinical practice?

Authors:  Marina Savastano; Luciano Giacomelli; Gino Marioni
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-10-11       Impact factor: 2.503

Review 4.  Ménière's disease.

Authors:  S N Merchant; S D Rauch; J B Nadol
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

5.  Allelic variants in TLR10 gene may influence bilateral affectation and clinical course of Meniere's disease.

Authors:  Teresa Requena; Irene Gazquez; Antonia Moreno; Angel Batuecas; Ismael Aran; Andres Soto-Varela; Sofia Santos-Perez; Nicolas Perez; Herminio Perez-Garrigues; Alicia Lopez-Nevot; Eduardo Martin; Ricardo Sanz; Paz Perez; Gabriel Trinidad; Marta E Alarcon-Riquelme; Roberto Teggi; Laura Zagato; Miguel A Lopez-Nevot; Jose A Lopez-Escamez
Journal:  Immunogenetics       Date:  2013-02-01       Impact factor: 2.846

Review 6.  Autoimmune vertigo: an update on vestibular disorders associated with autoimmune mechanisms.

Authors:  Francesca Yoshie Russo; Massimo Ralli; Daniele De Seta; Patrizia Mancini; Alessandro Lambiase; Marco Artico; Marco de Vincentiis; Antonio Greco
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

Review 7.  Vertigo and autoimmunity.

Authors:  Roberto Bovo; Andrea Ciorba; Alessandro Martini
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-10-16       Impact factor: 2.503

8.  Immune status in patients with Menière's disease.

Authors:  K L Evans; D L Baldwin; D Bainbridge; A W Morrison
Journal:  Arch Otorhinolaryngol       Date:  1988

9.  Incidence of virus infection as a cause of Meniere's disease or endolymphatic hydrops assessed by electrocochleography.

Authors:  Ziane Selmani; Timo Marttila; Ilmari Pyykkö
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-07-02       Impact factor: 2.503

10.  Innate immune recognition of molds and homology to the inner ear protein, cochlin, in patients with autoimmune inner ear disease.

Authors:  Shresh Pathak; Lynda J Hatam; Vincent Bonagura; Andrea Vambutas
Journal:  J Clin Immunol       Date:  2013-08-03       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.